WebView ePRO vs ObvioGo 2.0

WebView ePRO is a proprietary software application developed and supported by Amarex Clinical Research that is designed to collect health outcomes directly reported by the patient. An internet connection is required for access and data submission. WebView ePRO has two data collection modes: - Individual Patient Device Mode - Site Shared Device Mode The Individual Patient Device Mode is the regular data collection mode, in which each Patient will submit their diary data on their individual assigned devices. The Site Shared Device Mode collects Patient questionnaire data which will be entered on a shared device. Depending on the study design, the WebView ePRO will be setup for either data collection mode.

The ObvioGo™ app is a purpose-built mobile application designed to make clinical trial participation as easy and seamless as possible. As a pivotal piece of ObvioHealth’s configurable decentralized clinical trial (DCT) platform, this app enables participants to engage in clinical studies outside the traditional trial setting—from the comforts of home and as they go about their daily lives. The app’s features allow participants to provide consent, complete study tasks, report changes in health or medication, and communicate with the study team, all from the convenience of their personal iOS.